Recent studies have reported a role of KLK6 in the regulation of membrane-dependent signaling processes [54], and in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease [55]. This evidence concerns the gene KLK6 and early-onset autosomal dominant Alzheimer disease.